The Non-Malignant Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2020 | David C. Fajgenbaum: Chasing My Cure
David C. Fajgenbaum, MD, MBA, MSc, FCPP, of the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, discusses his journey from caregiver, oncologist, patient, researcher and advocate connector. Additionally, Dr Fajgenbaum outlines his experience with idiopathic multicenter Castleman disease and the development of the Castleman Disease Collaborative Network. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
